Oncology Market Access (OMA) U.S. provides strategic and tactical insights into the evolving oncology landscape. Combining Kantar Health’s commercial and clinical expertise in oncology, OMA U.S. provides cutting-edge information and analysis on critical reimbursement, coverage and competitive issues in the U.S. oncology marketplace. This subscription helps pharmaceutical marketing and sales professionals more successfully position cancer drugs in an increasingly scrutinized and regulated oncology marketplace. The analyses are based on industry experience augmented by in-depth research with key stakeholders, including oncologists, payers, practice managers, patients and subject matter experts. From Kantar Health
You are here: / / Oncology Market Access U.S.